Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS
· Delayed Price · Currency is USD
5.20
-0.05 (-0.95%)
At close: Feb 6, 2025
Sumitomo Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 5, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,065 | 1,045 | 2,421 | 3,952 | 6,922 | 5,180 | Upgrade
|
| Market Cap Growth | 8.32% | -56.82% | -38.75% | -42.91% | 33.63% | -47.21% | Upgrade
|
| Enterprise Value | 3,999 | 3,527 | 2,604 | 4,995 | 8,376 | 6,785 | Upgrade
|
| Last Close Price | 5.20 | 2.40 | 6.38 | 10.22 | 18.75 | 13.10 | Upgrade
|
| PE Ratio | - | - | - | 8.51 | 13.62 | 13.68 | Upgrade
|
| PS Ratio | 0.60 | 0.50 | 0.58 | 0.86 | 1.48 | 1.15 | Upgrade
|
| PB Ratio | 1.35 | 1.01 | 0.79 | 0.71 | 1.18 | 0.88 | Upgrade
|
| P/TBV Ratio | - | - | - | 34.15 | 37.03 | - | Upgrade
|
| P/FCF Ratio | - | - | 92.74 | 20.09 | 5.91 | 14.51 | Upgrade
|
| P/OCF Ratio | - | - | 26.96 | 15.36 | 5.65 | 12.08 | Upgrade
|
| EV/Sales Ratio | 1.60 | 1.70 | 0.62 | 1.08 | 1.80 | 1.51 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 6.17 | 12.04 | 7.28 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 10.12 | 17.06 | 8.80 | Upgrade
|
| EV/FCF Ratio | -39.12 | - | 99.75 | 25.39 | 7.15 | 19.01 | Upgrade
|
| Debt / Equity Ratio | 2.25 | 2.74 | 0.85 | 0.42 | 0.45 | 0.50 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 2.89 | 3.78 | 3.14 | Upgrade
|
| Debt / FCF Ratio | - | - | 99.82 | 11.91 | 2.24 | 8.21 | Upgrade
|
| Asset Turnover | 0.39 | 0.31 | 0.45 | 0.43 | 0.40 | 0.46 | Upgrade
|
| Inventory Turnover | 1.39 | 1.21 | 1.85 | 1.64 | 1.61 | 1.77 | Upgrade
|
| Quick Ratio | 0.37 | 0.24 | 0.65 | 1.27 | 1.19 | 0.49 | Upgrade
|
| Current Ratio | 0.67 | 0.52 | 1.03 | 1.79 | 1.65 | 0.73 | Upgrade
|
| Return on Equity (ROE) | -69.06% | -111.89% | -17.90% | 6.14% | 5.75% | 6.36% | Upgrade
|
| Return on Assets (ROA) | -14.65% | -21.74% | -6.47% | 2.87% | 2.65% | 4.97% | Upgrade
|
| Return on Capital (ROIC) | -21.62% | -33.20% | -9.23% | 3.95% | 3.60% | 7.01% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | - | 5.82% | 5.27% | 10.96% | Upgrade
|
| Earnings Yield | -54.21% | -199.19% | -23.15% | 11.75% | 7.34% | 7.31% | Upgrade
|
| FCF Yield | -4.95% | -159.79% | 1.08% | 4.98% | 16.92% | 6.89% | Upgrade
|
| Dividend Yield | 0.00% | - | 2.48% | 2.26% | 1.35% | 1.99% | Upgrade
|
| Payout Ratio | 0.00% | - | - | 19.72% | 19.78% | 32.16% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Total Shareholder Return | 0.00% | 0.00% | 2.48% | 2.26% | 1.35% | 1.99% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.